Published in Nat Genet on December 01, 1999
Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res (2008) 10.10
An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol (2009) 7.47
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Single-RNA counting reveals alternative modes of gene expression in yeast. Nat Struct Mol Biol (2008) 6.09
An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A (2002) 4.45
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A (2004) 3.95
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A (2000) 3.44
Genes that distinguish physiological and pathological angiogenesis. Cancer Cell (2007) 3.35
The use of MPSS for whole-genome transcriptional analysis in Arabidopsis. Genome Res (2004) 3.30
Mechanisms of apoptosis. Am J Pathol (2000) 3.23
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res (2006) 3.22
Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol (2011) 3.12
Chromatin-associated periodicity in genetic variation downstream of transcriptional start sites. Science (2008) 3.10
Identifying novel transcripts and novel genes in the human genome by using novel SAGE tags. Proc Natl Acad Sci U S A (2002) 2.87
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing. Proc Natl Acad Sci U S A (2003) 2.64
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest (2004) 2.59
HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J (2003) 2.47
Efficient frequency-based de novo short-read clustering for error trimming in next-generation sequencing. Genome Res (2009) 2.36
Exploration and visualization of gene expression with neuroanatomy in the adult mouse brain. BMC Bioinformatics (2008) 2.27
Housekeeping and tissue-specific genes in mouse tissues. BMC Genomics (2007) 2.06
General statistics of stochastic process of gene expression in eukaryotic cells. Genetics (2002) 2.06
Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest (2001) 2.05
Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A (2001) 1.89
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A (2001) 1.89
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem (2008) 1.71
The Survivin saga goes in vivo. J Clin Invest (2001) 1.66
A quantitative evaluation of SAGE. Genome Res (2000) 1.57
Assessment of SAGE in transcript identification. Genome Res (2003) 1.52
Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res (2000) 1.49
Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene (2004) 1.49
A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest (2004) 1.48
Gene length and proximity to neighbors affect genome-wide expression levels. Genome Res (2003) 1.47
The pattern of gene expression in human CD34(+) stem/progenitor cells. Proc Natl Acad Sci U S A (2001) 1.45
The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res (2000) 1.40
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.33
Strong-association-rule mining for large-scale gene-expression data analysis: a case study on human SAGE data. Genome Biol (2002) 1.32
Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther (2010) 1.30
RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics (2012) 1.28
Screening poly(dA/dT)- cDNAs for gene identification. Proc Natl Acad Sci U S A (2000) 1.27
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood (2012) 1.25
Deep analysis of cellular transcriptomes - LongSAGE versus classic MPSS. BMC Genomics (2007) 1.21
The pattern of gene expression in human CD15+ myeloid progenitor cells. Proc Natl Acad Sci U S A (2001) 1.21
High-resolution analysis of the 5'-end transcriptome using a next generation DNA sequencer. PLoS One (2009) 1.19
Limitations of mRNA amplification from small-size cell samples. BMC Genomics (2005) 1.19
A combination of LongSAGE with Solexa sequencing is well suited to explore the depth and the complexity of transcriptome. BMC Genomics (2008) 1.18
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res (2010) 1.15
SAGE analysis of transcriptome responses in Arabidopsis roots exposed to 2,4,6-trinitrotoluene. Plant Physiol (2003) 1.14
Reproducibility, bioinformatic analysis and power of the SAGE method to evaluate changes in transcriptome. Nucleic Acids Res (2005) 1.14
Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling. Proc Natl Acad Sci U S A (2000) 1.14
Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biol (2009) 1.14
Targeting caspases in cancer therapeutics. Biol Chem (2013) 1.13
Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies. Nucleic Acids Res (2010) 1.13
Large-scale identification of novel transcripts in the human genome. Genome Res (2007) 1.13
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br J Cancer (2005) 1.12
Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest (2002) 1.12
Intra-organ variation in age-related mutation accumulation in the mouse. PLoS One (2007) 1.11
A comparative molecular analysis of developing mouse forelimbs and hindlimbs using serial analysis of gene expression (SAGE). Genome Res (2001) 1.11
Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol (2006) 1.10
Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. Blood (2009) 1.09
The Retinome - defining a reference transcriptome of the adult mammalian retina/retinal pigment epithelium. BMC Genomics (2004) 1.07
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Can Zipf's law be adapted to normalize microarrays? BMC Bioinformatics (2005) 1.06
Stochastic model of protein-protein interaction: why signaling proteins need to be colocalized. Proc Natl Acad Sci U S A (2004) 1.04
SAGE is far more sensitive than EST for detecting low-abundance transcripts. BMC Genomics (2004) 1.02
Identification and confirmation of a module of coexpressed genes. Genome Res (2002) 1.01
Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer (2010) 1.01
Incidence of "quasi-ditags" in catalogs generated by Serial Analysis of Gene Expression (SAGE). BMC Bioinformatics (2004) 1.00
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro Oncol (2011) 0.99
Survivin monomer plays an essential role in apoptosis regulation. J Biol Chem (2011) 0.99
Druggable protein interaction sites are more predisposed to surface pocket formation than the rest of the protein surface. PLoS Comput Biol (2013) 0.98
Heritable change caused by transient transcription errors. PLoS Genet (2013) 0.97
Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Am J Dermatopathol (2004) 0.97
Modelling and measuring single cell RNA expression levels find considerable transcriptional differences among phenotypically identical cells. BMC Genomics (2008) 0.97
A quantitative view of the transcriptome of Schistosoma mansoni adult-worms using SAGE. BMC Genomics (2007) 0.97
Identifying expressed genes. Proc Natl Acad Sci U S A (2000) 0.97
Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis. PLoS One (2013) 0.96
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Mol Cancer Ther (2007) 0.96
Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist. Oncogene (2006) 0.95
Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol (2009) 0.95
5'SAGE: 5'-end Serial Analysis of Gene Expression database. Nucleic Acids Res (2005) 0.94
The +4G site in Kozak consensus is not related to the efficiency of translation initiation. PLoS One (2007) 0.93
Cytoskeleton remodeling and alterations in smooth muscle contractility in the bovine jejunum during nematode infection. Funct Integr Genomics (2011) 0.92
Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells. Cancer Lett (2011) 0.92
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res (2012) 0.92
Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res (2001) 0.91
TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin. Cell Death Dis (2013) 0.91
Activation of dual apoptotic pathways in human melanocytes and protection by survivin. J Invest Dermatol (2006) 0.91
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer. BMC Cancer (2010) 0.91
Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes. Haematologica (2012) 0.91
Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer. J Exp Clin Cancer Res (2009) 0.91
Prognostic relevance of survivin in pancreatic endocrine tumors. World J Surg (2012) 0.91
Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int J Oncol (2012) 0.90
Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol (2005) 0.90
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. Cancer Immunol Immunother (2010) 0.90
Genome-wide comprehensive analysis of human helicases. Commun Integr Biol (2011) 0.90
Probes for intracellular RNA imaging in live cells. Methods Enzymol (2012) 0.89
What can we do about osteoarthritis? Arthritis Res (2000) 0.89
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. J Pediatr Hematol Oncol (2014) 0.89
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Serial analysis of gene expression. Science (1995) 60.15
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2000) 34.79
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80
Genetic instabilities in human cancers. Nature (1998) 22.76
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2001) 19.13
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med (1999) 14.30
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A (1990) 14.22
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Definition of a consensus binding site for p53. Nat Genet (1992) 12.76
Genetic instability in colorectal cancers. Nature (1997) 12.51
A model for p53-induced apoptosis. Nature (1997) 11.38
Characterization of the yeast transcriptome. Cell (1997) 11.33
Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20
Genes expressed in human tumor endothelium. Science (2000) 10.75
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med (1996) 10.62
Digital PCR. Proc Natl Acad Sci U S A (1999) 10.54
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (1992) 10.12
The RNA component of human telomerase. Science (1995) 9.86
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature (1995) 9.03
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut (2009) 8.98
A public database for gene expression in human cancers. Cancer Res (1999) 8.81
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (1991) 8.41
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med (1995) 8.23
PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell (2001) 7.95
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90
p53 function and dysfunction. Cell (1992) 7.73
Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tob Control (2003) 7.51
Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (1990) 7.23
14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell (1997) 7.20
Association of the APC tumor suppressor protein with catenins. Science (1993) 7.17
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (1992) 6.73
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61
Identification of p53 as a sequence-specific DNA-binding protein. Science (1991) 6.60
A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36
Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest (1999) 6.13
The multistep nature of cancer. Trends Genet (1993) 6.12
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (1996) 6.11
Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell (1998) 5.88
Cancer-susceptibility genes. Gatekeepers and caretakers. Nature (1997) 5.87
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res (1998) 5.80
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature (1999) 5.44
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res (1995) 5.26
Selective solubilization of proteins from red blood cell membranes by protein perturbants. J Supramol Struct (1973) 5.18
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (1994) 5.12
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell (1999) 5.12
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Role of BAX in the apoptotic response to anticancer agents. Science (2000) 5.07
A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol (1993) 5.02
Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct (1973) 4.95
Ligand binding to integrins. J Biol Chem (2000) 4.94
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev (1995) 4.94
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature (2000) 4.68
Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet (1998) 4.67
Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature (1992) 4.63
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36